{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T20:10:12Z","timestamp":1794859812580,"version":"4.9.1"},"reference-count":77,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["RS-2024-00439928"],"award-info":[{"award-number":["RS-2024-00439928"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["RS-2019-NR040055"],"award-info":[{"award-number":["RS-2019-NR040055"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["RS-2023-00262332"],"award-info":[{"award-number":["RS-2023-00262332"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["RS-2025-00515932"],"award-info":[{"award-number":["RS-2025-00515932"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.neurot.2025.e00807","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T20:27:44Z","timestamp":1764188864000},"page":"e00807","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Uncovering the role of c-Fos in the bidirectional relationship between depression\/anxiety behaviors and \u03b1-synuclein propagation in Parkinson\u2019s disease"],"prefix":"10.1016","volume":"23","author":[{"given":"Soo-Jeong","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Bong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seonghui","family":"Ham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Myun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10291","key":"10.1016\/j.neurot.2025.e00807_bib1","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"issue":"47","key":"10.1016\/j.neurot.2025.e00807_bib2","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2018.33.e300","article-title":"Psychiatric manifestation in patients with Parkinson\u2019s Disease","volume":"33","author":"Han","year":"2018","journal-title":"J Kor Med Sci"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00807_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cger.2019.08.002","article-title":"Parkinson disease epidemiology, pathology, genetics, and pathophysiology","volume":"36","author":"Simon","year":"2020","journal-title":"Clin Geriatr Med"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00807_bib4","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nrn.2017.62","article-title":"Non-motor features of Parkinson disease","volume":"18","author":"Schapira","year":"2017","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00807_bib5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/mds.25664","article-title":"Health-related quality of life in early Parkinson\u2019s disease: the impact of nonmotor symptoms","volume":"29","author":"Duncan","year":"2014","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurot.2025.e00807_bib6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.neubiorev.2015.11.014","article-title":"Health-related quality of life in patients with Parkinson\u2019s disease\u2014a systematic review based on the ICF model","volume":"61","author":"van Uem","year":"2016","journal-title":"Neurosci Biobehav Rev"},{"issue":"1-2","key":"10.1016\/j.neurot.2025.e00807_bib7","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jad.2011.01.021","article-title":"Factors associated with depression in Parkinson\u2019s disease","volume":"132","author":"Dissanayaka","year":"2011","journal-title":"J Affect Disord"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00807_bib8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3233\/JPD-150705","article-title":"Self-Perceived pre-motor symptoms load in patients with Parkinson\u2019s disease: a retrospective study","volume":"6","author":"Rodr\u00edguez-Violante","year":"2016","journal-title":"J Parkinsons Dis"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00807_bib9","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jagp.2019.03.002","article-title":"The neuropsychiatry of parkinson disease: a perfect storm","volume":"27","author":"Weintraub","year":"2019","journal-title":"Am J Geriatr Psychiatr"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00807_bib10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/mds.21803","article-title":"A systematic review of prevalence studies of depression in Parkinson\u2019s disease","volume":"23","author":"Reijnders","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurot.2025.e00807_bib11","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.parkreldis.2019.05.009","article-title":"Predictors of health-related quality of life in Parkinson\u2019s disease","volume":"65","author":"Kuhlman","year":"2019","journal-title":"Park Relat Disord"},{"key":"10.1016\/j.neurot.2025.e00807_bib12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jns.2016.12.060","article-title":"Neuropsychiatric symptoms, behavioural disorders, and quality of life in Parkinson\u2019s disease","volume":"373","author":"Balestrino","year":"2017","journal-title":"J Neurol Sci"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00807_bib13","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/mds.21333","article-title":"Depression rating scales in Parkinson\u2019s disease: critique and recommendations","volume":"22","author":"Schrag","year":"2007","journal-title":"Mov Disord"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00807_bib14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/jnnp.55.5.377","article-title":"A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson\u2019s disease","volume":"55","author":"Starkstein","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00807_bib15","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/mds.21455","article-title":"Cognitive-behavioral therapy for depression in Parkinson\u2019s disease: a pilot study","volume":"22","author":"Dobkin","year":"2007","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00807_bib16","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1600-0404.2004.00292.x","article-title":"Mortality in Parkinson\u2019s disease and its association with dementia and depression","volume":"110","author":"Hughes","year":"2004","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00807_bib17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurot.2025.e00807_bib18","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/B978-0-444-63945-5.00017-9","article-title":"Prion-like propagation of pathology in Parkinson disease","volume":"153","author":"Volpicelli-Daley","year":"2018","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.neurot.2025.e00807_bib19","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a024380","article-title":"The transcellular propagation and intracellular trafficking of \u03b1-synuclein","volume":"7","author":"Tofaris","year":"2017","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"20","key":"10.1016\/j.neurot.2025.e00807_bib20","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1212\/01.wnl.0000312279.49272.9f","article-title":"Invited article: nervous system pathology in sporadic Parkinson disease","volume":"70","author":"Braak","year":"2008","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00807_bib21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13024-018-0241-0","article-title":"Extracellular \u03b1-synuclein levels are regulated by neuronal activity","volume":"13","author":"Yamada","year":"2018","journal-title":"Mol Neurodegener"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00807_bib22","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s40478-019-0814-3","article-title":"Chronic nigral neuromodulation aggravates behavioral deficits and synaptic changes in an \u03b1-synuclein based rat model for Parkinson\u2019s disease","volume":"7","author":"Torre-Muruzabal","year":"2019","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00807_bib23","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nn.2801","article-title":"Neuronal activity regulates the regional vulnerability to amyloid-\u03b2 deposition","volume":"14","author":"Bero","year":"2011","journal-title":"Nat Neurosci"},{"issue":"8","key":"10.1016\/j.neurot.2025.e00807_bib24","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/nn.4328","article-title":"Neuronal activity enhances tau propagation and tau pathology in vivo","volume":"19","author":"Wu","year":"2016","journal-title":"Nat Neurosci"},{"issue":"1-2","key":"10.1016\/j.neurot.2025.e00807_bib25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0166-4328(93)90098-B","article-title":"Hippocampal 5-HT receptors and consolidation of stressful memories","volume":"58","author":"Guimar\u00e3es","year":"1993","journal-title":"Behav Brain Res"},{"issue":"3-4","key":"10.1016\/j.neurot.2025.e00807_bib26","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0361-9230(93)90225-Z","article-title":"Stress-induced c-fos expression in the rat brain: activation mechanism of sympathetic pathway","volume":"31","author":"Senba","year":"1993","journal-title":"Brain Res Bull"},{"issue":"1-2","key":"10.1016\/j.neurot.2025.e00807_bib27","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0006-8993(95)00882-Q","article-title":"Adrenoceptor antagonists block c-fos response to stress in the mouse brain","volume":"694","author":"Stone","year":"1995","journal-title":"Brain Res"},{"issue":"3","key":"10.1016\/j.neurot.2025.e00807_bib28","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0922-4106(95)90003-9","article-title":"Chronic fluoxetine or desmethylimipramine treatment alters 5-HT2 receptor mediated c-fos gene expression","volume":"290","author":"Tilakaratne","year":"1995","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00807_bib29","first-page":"1083","article-title":"Stress-induced expression of the c-fos proto-oncogene in the hippocampal formation","volume":"27","author":"Titze-de-Almeida","year":"1994","journal-title":"Braz J Med Biol Res"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00807_bib30","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0306-4522(99)00459-5","article-title":"c-fos expression, behavioural, endocrine and autonomic responses to acute social stress in male rats after chronic restraint: modulation by serotonin","volume":"95","author":"Chung","year":"2000","journal-title":"Neuroscience"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00807_bib31","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0306-4522(94)00355-9","article-title":"Pattern and time course of immediate early gene expression in rat brain following acute stress","volume":"64","author":"Cullinan","year":"1995","journal-title":"Neuroscience"},{"issue":"11","key":"10.1016\/j.neurot.2025.e00807_bib32","first-page":"1321","article-title":"Induction and habituation of c-fos and zif\/268 by acute and repeated stressors","volume":"5","author":"Watanabe","year":"1994","journal-title":"Neuroreport"},{"key":"10.1016\/j.neurot.2025.e00807_bib33","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fnbeh.2014.00043","article-title":"Optogenetic modulation of descending prefrontocortical inputs to the dorsal raphe bidirectionally bias socioaffective choices after social defeat","volume":"8","author":"Challis","year":"2014","journal-title":"Front Behav Neurosci"},{"issue":"7433","key":"10.1016\/j.neurot.2025.e00807_bib34","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nature11713","article-title":"Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons","volume":"493","author":"Chaudhury","year":"2013","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00807_bib35","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.celrep.2015.10.061","article-title":"Activity of raph\u00e9 serotonergic neurons controls emotional behaviors","volume":"13","author":"Teissier","year":"2015","journal-title":"Cell Rep"},{"issue":"7429","key":"10.1016\/j.neurot.2025.e00807_bib36","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature11617","article-title":"A prefrontal cortex-brainstem neuronal projection that controls response to behavioural challenge","volume":"492","author":"Warden","year":"2012","journal-title":"Nature"},{"issue":"28","key":"10.1016\/j.neurot.2025.e00807_bib37","doi-asserted-by":"crossref","first-page":"6340","DOI":"10.1523\/JNEUROSCI.2780-17.2018","article-title":"Brain circuits mediating opposing effects on emotion and pain","volume":"38","author":"Cai","year":"2018","journal-title":"J Neurosci"},{"key":"10.1016\/j.neurot.2025.e00807_bib38","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.psyneuen.2017.12.003","article-title":"Inability to suppress the stress-induced activation of the HPA axis during the peripartum period engenders deficits in postpartum behaviors in mice","volume":"90","author":"Mel\u00f3n","year":"2018","journal-title":"Psychoneuroendocrinology"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00807_bib39","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201948950","article-title":"The dual role of c-src in cell-to-cell transmission of \u03b1-synuclein","volume":"21","author":"Choi","year":"2020","journal-title":"EMBO Rep"},{"key":"10.1016\/j.neurot.2025.e00807_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116442","article-title":"Artificial intelligence-driven drug repositioning uncovers efavirenz as a modulator of \u03b1-synuclein propagation: implications in Parkinson\u2019s disease","volume":"174","author":"Kim","year":"2024","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00807_bib41","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12993-021-00175-z","article-title":"Susceptibility to chronic immobilization stress-induced depressive-like behaviour in middle-aged female mice and accompanying changes in dopamine D1 and GABAA receptors in related brain regions","volume":"17","author":"Cao","year":"2021","journal-title":"Behav Brain Funct"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00807_bib42","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12974-024-03041-7","article-title":"Integration of National Health Insurance claims data and animal models reveals fexofenadine as a promising repurposed drug for Parkinson\u2019s disease","volume":"21","author":"Kim","year":"2024","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.neurot.2025.e00807_bib43","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.bbi.2016.10.001","article-title":"Reconsidering the role of glial cells in chronic stress-induced dopaminergic neurons loss within the substantia nigra? Friend or foe?","volume":"60","author":"Ong","year":"2017","journal-title":"Brain Behav Immun"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00807_bib44","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s12974-019-1632-z","article-title":"Stress-induced microglial activation occurs through \u03b2-adrenergic receptor: noradrenaline as a key neurotransmitter in microglial activation","volume":"16","author":"Sugama","year":"2019","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.neurot.2025.e00807_bib45","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.physbeh.2017.01.046","article-title":"Chronic mild stress augments MPTP induced neurotoxicity in a murine model of Parkinson\u2019s disease","volume":"173","author":"Janakiraman","year":"2017","journal-title":"Physiol Behav"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00807_bib46","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s11011-017-9988-1","article-title":"Post 6-OHDA lesion exposure to stress affects neurotrophic factor expression and aggravates motor impairment","volume":"32","author":"Ngema","year":"2017","journal-title":"Metab Brain Dis"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00807_bib47","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1084\/jem.20112457","article-title":"Intracerebral inoculation of pathological \u03b1-synuclein initiates a rapidly progressive neurodegenerative \u03b1-synucleinopathy in mice","volume":"209","author":"Luk","year":"2012","journal-title":"J Exp Med"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00807_bib48","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/cne.902960402","article-title":"Expression of c-fos-like protein as a marker for neuronal activity following noxious stimulation in the rat","volume":"296","author":"Bullitt","year":"1990","journal-title":"J Comp Neurol"},{"issue":"17","key":"10.1016\/j.neurot.2025.e00807_bib49","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1021\/jm049890+","article-title":"Design, synthesis, and biological evaluation of new cyclic disulfide decapeptides that inhibit the binding of AP-1 to DNA","volume":"47","author":"Tsuchida","year":"2004","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00807_bib50","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1021\/jm050550d","article-title":"Discovery of nonpeptidic small-molecule AP-1 inhibitors: lead hopping based on a three-dimensional pharmacophore model","volume":"49","author":"Tsuchida","year":"2006","journal-title":"J Med Chem"},{"issue":"23","key":"10.1016\/j.neurot.2025.e00807_bib51","doi-asserted-by":"crossref","first-page":"6593","DOI":"10.1111\/febs.15674","article-title":"Molecular events underlying the cell-to-cell transmission of \u03b1-synuclein","volume":"288","author":"Choi","year":"2021","journal-title":"FEBS J"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00807_bib52","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12974-021-02079-1","article-title":"Metabotropic glutamate receptor 5 inhibits \u03b1-synuclein-induced microglia inflammation to protect from neurotoxicity in Parkinson\u2019s disease","volume":"18","author":"Zhang","year":"2021","journal-title":"J Neuroinflammation"},{"issue":"5","key":"10.1016\/j.neurot.2025.e00807_bib53","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s10059-010-0140-x","article-title":"NMDA receptor, PKC and ERK prevent fos expression induced by the activation of group I metabotropic glutamate receptors in the spinal trigeminal subnucleus oralis","volume":"30","author":"Park","year":"2010","journal-title":"Mol Cells"},{"key":"10.1016\/j.neurot.2025.e00807_bib54","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.expneurol.2013.11.009","article-title":"Alpha-synuclein interferes with cAMP\/PKA-dependent upregulation of dopamine \u03b2-hydroxylase and is associated with abnormal adaptive responses to immobilization stress","volume":"252","author":"Kim","year":"2014","journal-title":"Exp Neurol"},{"issue":"22","key":"10.1016\/j.neurot.2025.e00807_bib55","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1021\/acschemneuro.0c00628","article-title":"Sirt1\/FoxO1-Associated MAO-A upregulation promotes depressive-like behavior in transgenic mice expressing human A53T \u03b1-Synuclein","volume":"11","author":"Li","year":"2020","journal-title":"ACS Chem Neurosci"},{"issue":"2","key":"10.1016\/j.neurot.2025.e00807_bib56","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.parkreldis.2008.04.038","article-title":"The neuropathological basis for depression in Parkinson\u2019s disease","volume":"15","author":"Frisina","year":"2009","journal-title":"Park Relat Disord"},{"issue":"9","key":"10.1016\/j.neurot.2025.e00807_bib57","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1002\/mds.28512","article-title":"\u03b1-Synuclein spread from Olfactory Bulb causes hyposmia, anxiety, and memory loss in BAC-SNCA mice","volume":"36","author":"Uemura","year":"2021","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurot.2025.e00807_bib58","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.clineuro.2017.06.010","article-title":"Premotor symptoms and the risk of Parkinson\u2019s disease: a case-control study in Mexican population","volume":"160","author":"Rodr\u00edguez-Violante","year":"2017","journal-title":"Clin Neurol Neurosurg"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00807_bib59","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1017\/S1041610215002410","article-title":"Disease-specific anxiety symptomatology in Parkinson\u2019s disease","volume":"28","author":"Dissanayaka","year":"2016","journal-title":"Int Psychogeriatr"},{"issue":"4","key":"10.1016\/j.neurot.2025.e00807_bib60","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1152\/physrev.00013.2009","article-title":"The function of activity-regulated genes in the nervous system","volume":"89","author":"Loebrich","year":"2009","journal-title":"Physiol Rev"},{"key":"10.1016\/j.neurot.2025.e00807_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104708","article-title":"Behavioral defects associated with amygdala and cortical dysfunction in mice with seeded \u03b1-synuclein inclusions","volume":"134","author":"Stoyka","year":"2020","journal-title":"Neurobiol Dis"},{"issue":"6","key":"10.1016\/j.neurot.2025.e00807_bib62","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/cne.23901","article-title":"Brain region-dependent differential expression of alpha-synuclein","volume":"524","author":"Taguchi","year":"2016","journal-title":"J Comp Neurol"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00807_bib63","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s004010000270","article-title":"Cortical neurons expressing calcium binding proteins are spared in dementia with lewy bodies","volume":"101","author":"G\u00f3mez-Tortosa","year":"2001","journal-title":"Acta Neuropathol"},{"issue":"5896","key":"10.1016\/j.neurot.2025.e00807_bib64","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1126\/science.1162844","article-title":"Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer\u2019s disease","volume":"321","author":"Busche","year":"2008","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00807_bib65","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1038\/nn.4163","article-title":"Decreased amyloid-\u03b2 and increased neuronal hyperactivity by immunotherapy in Alzheimer\u2019s models","volume":"18","author":"Busche","year":"2015","journal-title":"Nat Neurosci"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00807_bib66","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1002\/mds.28558","article-title":"Perampanel inhibits \u03b1-synuclein transmission in Parkinson\u2019s disease models","volume":"36","author":"Ueda","year":"2021","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurot.2025.e00807_bib67","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1471-2369-13-153","article-title":"The effects of a selective inhibitor of c-Fos\/activator protein-1 on endotoxin-induced acute kidney injury in mice","volume":"13","author":"Miyazaki","year":"2012","journal-title":"BMC Nephrol"},{"issue":"12","key":"10.1016\/j.neurot.2025.e00807_bib68","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1007\/s10529-012-1022-4","article-title":"T-5224, a selective inhibitor of c-Fos\/activator protein-1, attenuates lipopolysaccharide-induced liver injury in mice","volume":"34","author":"Izuta","year":"2012","journal-title":"Biotechnol Lett"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00807_bib69","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1750-1326-9-18","article-title":"Hippocampal neuronal cells that accumulate \u03b1-synuclein fragments are more vulnerable to A\u03b2 oligomer toxicity via mGluR5\u2013implications for dementia with lewy bodies","volume":"9","author":"Overk","year":"2014","journal-title":"Mol Neurodegener"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00807_bib70","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13041-023-01074-2","article-title":"In vitro modulation of mTOR and mGlur5 influence \u03b1-synuclein accumulation","volume":"17","author":"Xing","year":"2024","journal-title":"Mol Brain"},{"issue":"7","key":"10.1016\/j.neurot.2025.e00807_bib71","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0166-2236(96)20019-0","article-title":"Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders?","volume":"19","author":"Nicoletti","year":"1996","journal-title":"Trends Neurosci"},{"issue":"19","key":"10.1016\/j.neurot.2025.e00807_bib72","doi-asserted-by":"crossref","first-page":"13361","DOI":"10.1016\/S0021-9258(18)42219-3","article-title":"Molecular characterization of a novel metabotropic glutamate receptor mGluR5 coupled to inositol phosphate\/Ca2+ signal transduction","volume":"267","author":"Abe","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neurot.2025.e00807_bib73","article-title":"Increased Homer1-mGluR5 mediates chronic stress-induced depressive-like behaviors and glutamatergic dysregulation via activation of PERK-eIF2\u03b1","volume":"95","author":"Li","year":"2019","journal-title":"Prog Neuro Psychopharmacol Biol Psychiatr"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00807_bib74","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/ejn.14603","article-title":"Optogenetic and chemogenetic insights into the neurocircuitry of depression-like behaviour: a systematic review","volume":"53","author":"Biselli","year":"2021","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neurot.2025.e00807_bib75","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neurobiolaging.2019.08.007","article-title":"Chronic corticosterone aggravates behavioral and neuronal symptomatology in a mouse model of alpha-synuclein pathology","volume":"83","author":"Burtscher","year":"2019","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurot.2025.e00807_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2022.931964","article-title":"Encore: behavioural animal models of stress, depression and mood disorders","volume":"16","author":"Petkovic","year":"2022","journal-title":"Front Behav Neurosci"},{"issue":"1","key":"10.1016\/j.neurot.2025.e00807_bib77","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18010198","article-title":"Gender differences and quality of life in Parkinson\u2019s Disease","volume":"18","author":"Crispino","year":"2020","journal-title":"Int J Environ Res Publ Health"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925002855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747925002855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T04:07:11Z","timestamp":1775189231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747925002855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1878747925002855"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00807","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uncovering the role of c-Fos in the bidirectional relationship between depression\/anxiety behaviors and \u03b1-synuclein propagation in Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2025.e00807","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00807"}}